The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

JG Wildenbeest, MN Billard, RP Zuurbier… - The Lancet …, 2023 - thelancet.com
Background Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants.
The burden of RSV infection in healthy term infants has not yet been established. Accurate …

Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial

…, NI Mazur, JG Wildenbeest… - The Lancet …, 2018 - thelancet.com
Background Respiratory syncytial virus (RSV) infection is associated with subsequent wheeze
and asthma. We previously reported on the causal relationship between prevention of …

The need for treatment against human parechoviruses: how, why and when?

JG Wildenbeest, H Harvala, D Pajkrt… - Expert review of anti …, 2010 - Taylor & Francis
… Indeed, HPeV infections are highly prevalent in children and shedding of viral particles or
nucleic acid may occur for weeks [Wildenbeest JG et al., Unpublished Data]. Detection of …

International changes in respiratory syncytial virus (RSV) epidemiology during the COVID‐19 pandemic: association with school closures

…, LJ Bont, JG Wildenbeest - Influenza and other …, 2022 - Wiley Online Library
Background Little RSV activity was observed during the first expected RSV season since the
COVID‐19 pandemic. Multiple countries later experienced out‐of‐season RSV resurgences…

Outpatient respiratory syncytial virus infections and novel preventive interventions

SF Hak, RP Venekamp, JG Wildenbeest… - Current Opinion in …, 2024 - journals.lww.com
Novel RSV immunizations hold promise to reduce the RSV burden in infants, with substantial
impact on everyday practice. Tailored parental guidance will be instrumental for successful …

Specific cell tropism and neutralization of human parechovirus types 1 and 3: implications for pathogenesis and therapy development

…, G Koen, JG Wildenbeest… - Journal of general …, 2012 - microbiologyresearch.org
Human parechoviruses (HPeVs) are picornaviruses frequently infecting humans. While
HPeV1 is associated with mild disease, HPeV3 is the cause of neonatal sepsis and meningitis. …

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults

…, CC Butler, SB Drysdale, JG Wildenbeest… - Frontiers in …, 2023 - frontiersin.org
Introduction The immune mechanisms supporting partial protection from reinfection and
disease by the respiratory syncytial virus (RSV) have not been fully characterized. In older adults…

Successful IVIG treatment of human parechovirus-associated dilated cardiomyopathy in an infant

JG Wildenbeest, KC Wolthers, B Straver, D Pajkrt - Pediatrics, 2013 - publications.aap.org
… Dr Wildenbeest conceptualized and designed the case report, drafted the initial manuscript,
and approved the final manuscript as submitted; Dr Wolthers carried out the virological …

Neonate with Mycoplasma hominis meningoencephalitis given moxifloxacin

JG Wildenbeest, I Said, B Jaeger… - The Lancet Infectious …, 2016 - thelancet.com
Mycoplasma hominis is a commensal organism in the genitourinary tract that can cause life-threatening
CNS infections in neonates after intrauterine infection or through vertical …

World Health Organization influenza-like illness underestimates the burden of respiratory syncytial virus infection in community-dwelling older adults

…, TJM Verheij, LJ Bont, JG Wildenbeest - The Journal of …, 2022 - academic.oup.com
Background Respiratory syncytial virus (RSV) surveillance is heavily dependent on the
influenza-like illness (ILI) case definition from the World Health Organization (WHO). Because ILI …